Alexandria Real Estate Equities, Inc. on Friday announced the opening of Lilly Gateway Labs San Diego, powered by Alexandria, on the One Alexandria Square Megacampus in Torrey Pines. First launched by Eli Lilly and Company in 2019 in the Bay Area, Lilly Gateway Labs is a shared innovation hub designed to empower biotechnology companies to develop life-changing medicines, according to Alexandria.

“We value our nearly two-decade strategic relationship with Lilly, and we are honored to serve as an essential partner to expand the transformative Gateway Labs platform in San Diego,” said Hallie E. Kuhn, PhD, SVP and co-lead of life science and capital markets. “Our partnership embodies our shared mission to accelerate the trajectory of disruptive early-stage biotech companies and foster critical collaboration between innovative biotechs and large pharma.”

The new site, located in a LEED Gold-certified all-electric laboratory facility, features modular laboratory spaces with adjacent collaboration areas, scientific amenities, operational support services, strategic programming and dedicated building security and concierge services. 

From capital markets and investment strategies to development trends, leasing, and the evolving needs of healthcare providers, Connect Healthcare Real Estate 2025 dives into the most pressing issues shaping the sector, exploring how demographic shifts and economic forces are driving opportunity. Join us October 14–15, 2025, in Irvine to get ahead of what’s next in healthcare real estate:  www.ConnectHealthcareCRE2025.com